# Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation

> **NCT04209959** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 300 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** nifekalant

## Key facts

- **NCT ID:** NCT04209959
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04209959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04209959, "Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04209959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*